ADAMS introduction and aims

RIMS believes that adherence is more than taking medication regularly. Adherence is about personal lifestyle goals and choices, DMD treatment choices, rehabilitation and symptomatic treatment choices, vocational choices, relationship and family choices in a setting of multiple uncertainties and risks as person with Multiple Sclerosis. Assessment of existing knowledge and experiences in adherence in a chronic disease and the development of a joint proposal by the gathered panel of experts on further actions in this field – these are the two main aims of ADAMS. A first meeting with a small group of experts within but also outside the field of MS was held on April 19th 2013 in Brussels. More activities on the topic adherence will be planned in 2014.

 


Please find below some background reading on the ADAMS program. 

 

join button_small

Rims General Newsletter

Keep informed of news, events and recent publications at EURIMS by subscribing to our newsletter below.
Antispam

Sponsors

  • Logo Merck - Serono
  • Logo Teva
  • Logo Novartis
  • Logo Biogen
  • Logo Sanofi - Genzyme
  • Logo Ectrims